Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$112,209,199
+$1,444,095 QoQ
Shares Held
207,093
+10.9% QoQ
Ownership
0.483%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#46
of 870 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,567,388 | $256,352,500 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,916,666 | $132,696,643 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
207,093 | $112,209,199 | |
| 4 | VTRS |
Viatris Inc
|
4,069,647 | $64,625,993 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
314,451 | $52,997,570 | |
| 6 | ALKS |
Alkermes plc.
|
393,524 | $20,620,657 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
711,233 | $17,503,443 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,012,792 | $15,941,311 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,209,199 | 207,093 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $110,765,104 | 186,794 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $84,582,701 | 173,592 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $83,697,791 | 199,656 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $57,044,432 | 198,519 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $58,685,358 | 190,370 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $61,309,124 | 173,759 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $65,502,078 | 182,788 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $60,161,989 | 188,862 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $46,639,820 | 203,029 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $46,966,964 | 213,593 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $49,601,729 | 219,603 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $48,904,733 | 221,539 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $48,548,928 | 216,775 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $33,611,625 | 120,866 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $24,089,797 | 115,053 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,944,075 | 118,588 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $21,594,145 | 120,362 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,439,314 | 117,731 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,150,468 | 114,587 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,467,988 | 114,085 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $21,670,664 | 129,555 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,864,756 | 130,870 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $13,898,206 | 137,606 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $16,307,775 | 134,775 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,850,904 | 124,970 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||